ArticleThe Journal of allergy and clinical immunology2017

Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines.

Milena Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.